stars 1 stars 2 stars 3

As a multinational antibody manufacturer, GeneTex’s primary goal is to provide bioscience researchers with thoroughly validated reagents to accelerate their discovery. Established in 1997 in San Antonio, Texas by scientists with expertise in clinical oncology, cancer biology, and infectious disease, the company’s initial focus was breast cancer biology and prognostic marker research. This evolved to incorporate a comprehensive portfolio of immunological reagents used by scientists probing the underlying mechanisms common to many forms of cancer. GeneTex’s catalog has since expanded to offer a broad and diverse selection of antibody products covering a full range of research areas. GeneTex is proud to offer the highest quality antibody reagents supported by extensive research, development, and validation. We are committed to the highest standards of product performance.

GeneTex, Inc. Questions

The GeneTex, Inc. annual revenue was $26.6 million in 2026.

Joel Yguerabide is the Vice President, US Operations of GeneTex, Inc..

34 people are employed at GeneTex, Inc..

GeneTex, Inc. is based in Irvine, California.

The NAICS codes for GeneTex, Inc. are [54171, 32, 325414, 32541, 541, 325, 541711, 3254, 54, 5417].

The SIC codes for GeneTex, Inc. are [516, 51].

Top GeneTex, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users